Bloomberg Law Abortion Pill Cases Test Whether FDA Rules Preempt State Limits “The relationship between the FDA’s regulatory power and the state’s power to regulate the practice of medicine is a complicated one” and “the FDA’s involvement in mifepristone is much more complex than with most medications,” said Wendy Parmet, a health law professor at Northeastern University.